Author:
Fevrier Helene,LaPrise Andrew,Mbagwu Michael,Leng Theodore,Torres Aracelis Z.,Borkar Durga S.
Reference21 articles.
1. US Food and Drug Administration. Guidance document. Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products: Guidance for Industry,2023
2. US Food and Drug Administration. Guidance document. Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biologic Products,2021
3. Emulating control arms for cancer clinical trials using external cohorts created from electronic health record-derived real-world data;Tan;Clin Pharmacol Ther,2022
4. Claims-based cardiovascular outcome identification for clinical research: results from 7 large randomized cardiovascular clinical trials;Brennan;Am Heart J,2019
5. Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of pralsetinib in non-small cell lung cancer;Popat;Nat Commun,2022